FDA approves new drug for schizophrenia
The U.S. Food and Drug Administration has approved Latuda (lurasidone HCL) tables for the treatment of adults with schizophrenia. Read more here.
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.